News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
795,705 Results
Type
Article (76417)
Company Profile (314)
Press Release (718974)
Section
Business (221637)
Career Advice (3194)
Deals (38231)
Drug Delivery (118)
Drug Development (88256)
Employer Resources (187)
FDA (17333)
Job Trends (16474)
News (377062)
Policy (36635)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (10)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (10)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (7)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2980)
Academic (2)
Accelerated approval (5)
Adcomms (28)
Allergies (87)
Alliances (54539)
ALS (91)
Alzheimer's disease (1466)
Antibody-drug conjugate (ADC) (128)
Approvals (17314)
Artificial intelligence (267)
Autoimmune disease (21)
Automation (14)
Bankruptcy (385)
Best Places to Work (12437)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (210)
Bladder cancer (64)
Brain cancer (30)
Breast cancer (269)
Cancer (2137)
Cardiovascular disease (181)
Career advice (2699)
Career pathing (33)
CAR-T (155)
Cell therapy (438)
Cervical cancer (21)
Clinical research (70940)
Collaboration (832)
Compensation (476)
Complete response letters (25)
COVID-19 (2834)
CRISPR (41)
C-suite (232)
Cystic fibrosis (105)
Data (2031)
Decentralized trials (2)
Denatured (35)
Depression (47)
Diabetes (266)
Diagnostics (6761)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (122)
Drug pricing (114)
Drug shortages (29)
Duchenne muscular dystrophy (92)
Earnings (89840)
Editorial (40)
Employer branding (22)
Employer resources (159)
Events (123333)
Executive appointments (689)
FDA (18515)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (744)
Gene editing (108)
Generative AI (25)
Gene therapy (313)
GLP-1 (780)
Government (5003)
Grass and pollen (5)
Guidances (49)
Healthcare (20577)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (27)
Infectious disease (2978)
Inflammatory bowel disease (146)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (91)
Interviews (593)
IPO (17450)
IRA (49)
Job creations (4481)
Job search strategy (2262)
Kidney cancer (10)
Labor market (36)
Layoffs (527)
Leadership (21)
Legal (9055)
Liver cancer (74)
Lung cancer (310)
Lymphoma (136)
Machine learning (4)
Management (63)
Manufacturing (295)
MASH (64)
Medical device (14257)
Medtech (14262)
Mergers & acquisitions (21274)
Metabolic disorders (692)
Multiple sclerosis (78)
NASH (18)
Neurodegenerative disease (94)
Neuropsychiatric disorders (28)
Neuroscience (1998)
NextGen: Class of 2025 (7326)
Non-profit (5024)
Northern California (2510)
Now hiring (38)
Obesity (373)
Opinion (263)
Ovarian cancer (74)
Pain (89)
Pancreatic cancer (79)
Parkinson's disease (145)
Partnered (21)
Patents (217)
Patient recruitment (101)
Peanut (51)
People (63585)
Pharmaceutical (74)
Pharmacy benefit managers (20)
Phase I (22041)
Phase II (30973)
Phase III (23108)
Pipeline (1090)
Podcasts (88)
Policy (133)
Postmarket research (3241)
Preclinical (9898)
Press Release (72)
Prostate cancer (99)
Psychedelics (36)
Radiopharmaceuticals (263)
Rare diseases (395)
Real estate (6949)
Recruiting (71)
Regulatory (24702)
Reports (48)
Research institute (2637)
Resumes & cover letters (490)
Rett syndrome (4)
RNA editing (4)
RSV (45)
Schizophrenia (72)
Series A (132)
Series B (84)
Service/supplier (20)
Sickle cell disease (57)
Southern California (2184)
Special edition (18)
Spinal muscular atrophy (161)
Sponsored (32)
Startups (4042)
State (2)
Stomach cancer (15)
Supply chain (65)
Tariffs (14)
The Weekly (51)
United States (22311)
Vaccines (747)
Venture capitalists (39)
Webinars (13)
Weight loss (264)
Women's health (36)
Worklife (19)
Date
Today (58)
Last 7 days (693)
Last 30 days (2729)
Last 365 days (35135)
2025 (8782)
2024 (37046)
2023 (42057)
2022 (53424)
2021 (58264)
2020 (57178)
2019 (50735)
2018 (38573)
2017 (35610)
2016 (36156)
2015 (42568)
2014 (37021)
2013 (33545)
2012 (35495)
2011 (35492)
2010 (34962)
Location
Africa (1075)
Alabama (54)
Alaska (7)
Arizona (248)
Arkansas (14)
Asia (45673)
Australia (7997)
California (5750)
Canada (1916)
China (504)
Colorado (256)
Connecticut (276)
Delaware (132)
Europe (104062)
Florida (847)
Georgia (208)
Idaho (62)
Illinois (559)
India (26)
Indiana (308)
Iowa (9)
Japan (147)
Kansas (106)
Kentucky (25)
Louisiana (10)
Maine (61)
Maryland (881)
Massachusetts (4394)
Michigan (220)
Minnesota (394)
Mississippi (2)
Missouri (85)
Montana (31)
Nebraska (26)
Nevada (58)
New Hampshire (68)
New Jersey (1657)
New Mexico (31)
New York (1652)
North Carolina (1029)
North Dakota (8)
Northern California (2510)
Ohio (203)
Oklahoma (15)
Oregon (38)
Pennsylvania (1294)
Puerto Rico (10)
Rhode Island (28)
South America (1439)
South Carolina (19)
South Dakota (1)
Southern California (2184)
Tennessee (98)
Texas (866)
Utah (173)
Virginia (141)
Washington D.C. (62)
Washington State (533)
West Virginia (3)
Wisconsin (59)
795,705 Results for "university of georgia research foundation inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens
March 19, 2025
·
2 min read
Biotech Bay
AN2 Therapeutics Signs License Agreement with the University of Georgia Research Foundation to Develop Novel Boron-Based Therapy for Chagas Disease
AN2 Therapeutics, Inc. today announced that it has received an exclusive license from the University of Georgia Research Foundation to advance the development of a boron-containing small molecule for Chagas disease.
October 18, 2023
·
6 min read
Press Releases
Final Call for Biocodex Microbiota Foundation $50,000 2025 USA Microbiome Research Grant
April 2, 2025
·
2 min read
Press Releases
Lung Cancer Research Foundation Announces Research Collaboration with Israel Cancer Research Fund
February 19, 2025
·
5 min read
Press Releases
Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration
March 18, 2025
·
3 min read
Press Releases
Kaiser Permanente names Corwin N. Harper president of Georgia Region
January 17, 2025
·
3 min read
BioCapital
Empowering Change: AMCP Foundation partners with Moda Health and Novo Nordisk Inc., launching a Health Disparities Research Internship
Intern alumni from Moda Health and Novo Nordisk Inc. join forces with the AMCP Foundation for a groundbreaking Health Disparities research internship, appointing Daria Sinclair, a PharmD Candidate at Howard University, College of Pharmacy, as the inaugural intern.
April 3, 2024
·
4 min read
Biotech Bay
Nutcracker Therapeutics’ Research Partner, the University of California, San Francisco, Presents Foundational Prostate Cancer Data at AAI 2024
Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, detailed data presented by its partners at the University of California, San Francisco on foundational prostate cancer antigen research utilized to inform the development of its mRNA drug candidate, NTX-470.
May 15, 2024
·
4 min read
Impact Fusion International Inc. Announces the Commencement of a Research Project with Southern University Agricultural and Research Center (SUARC)
Impact Fusion International Inc. (OTC Pink: IFUS) The Company is pleased to announce that a research project with the Southern University Agricultural and Research Center (SUARC) has begun.
May 13, 2024
·
4 min read
Press Releases
Foundation for Sarcoidosis Research (FSR) Announces $300,000 in Grant Funding to Improve Diagnosis and Treatment of Sarcoidosis
February 3, 2025
·
3 min read
1 of 79,571
Next
